Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: JHP who wrote (32443)	9/9/1998 5:39:00 PM
From: Knighty Tin	Respond to of 132070

John, Columbia Labs is a speculative drug/biotech co. I kind of like the cut of their jib. First, I think concentrating on women's diseases and sexually transmitted diseases may be a bit limiting, but they can expand their scope later if they are successful. I have heard good word of mouth on the bioadhesive technique of delivery, but I haven't heard a thing about the products themselves. At these prices, I think COB is a buy in a diversified list of small medical/biotech companies. I wouldn't want to own it or any one of them on their own. Some will score homeruns and some will fail. COB seems to have a good chance, but don't bet the ranch on it. Good Luck, MB